View of The Utilisation of population pharmacokinetic-pharmacodynamic modelling in dosing individualisation: the example of radioactive iodine 131I in the treatment of benign thyroid diseases

Return to Article Details The Utilisation of population pharmacokinetic-pharmacodynamic modelling in dosing individualisation: the example of radioactive iodine 131I in the treatment of benign thyroid diseases Download Download PDF